Jane Street Group, LLC Cara Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$9.94 - $12.65 $422,450 - $537,625	-42,500 Reduced 29.35%	102,300 $1.24 Million
Q4 2021 Feb 15, 2022	BUY	$11.99 - $18.14 $268,576 - $406,336	22,400 Added 18.3%	144,800 $1.76 Million
Q3 2021 Nov 16, 2021	BUY	$11.55 - $16.06 $531,300 - $738,759	46,000 Added 60.21%	122,400 $1.89 Million
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $133,704 - $315,252	-10,800 Reduced 12.39%	76,400 $1.09 Million
Q1 2021 May 18, 2021	BUY	$15.07 - $21.71 $55,759 - $80,327	3,700 Added 4.43%	87,200 $1.89 Million
Q4 2020 Feb 17, 2021	BUY	$12.72 - $16.16 $686,880 - $872,640	54,000 Added 183.05%	83,500 $1.26 Million
Q3 2020 Nov 17, 2020	SELL	$12.34 - $17.92 $1.19 Million - $1.73 Million	-96,600 Reduced 76.61%	29,500 $375,000
Q2 2020 Aug 17, 2020	BUY	$12.39 - $17.33 $1.56 Million - $2.19 Million	126,100 New	126,100 $2.16 Million
Q4 2018 Feb 15, 2019	SELL	$12.45 - $23.47 $120,765 - $227,659	-9,700 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$17.57 - $23.95 $513,044 - $699,340	-29,200 Reduced 75.06%	9,700 $232,000
Q2 2018 Aug 15, 2018	BUY	$11.6 - $19.27 $1,160 - $1,927	100 Added 0.26%	38,900 $745,000
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $456,676 - $623,903	38,800 New	38,800 $480,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15.6M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.